October 5, 2010 Renal Biomarker Qualification Submission: A Dialog Between the FDA-EMEA and Predictive Safety Testing Consortium
C-Path is No. 7 in Reader’s Digest List of 18 Big Ideas to Fix Healthcare Now The November 2008 issue of Reader’s Digest lists 18 big ideas to fix healthcare now and the Critical Path Insitute is listed
FDA & EMEA to Consider Additional Test Results When Assessing New Drug Safety In the first use of a framework allowing submission of a single application to the two agencies, the Food and Drug Administration
FDA Soon May Support Biomarker Tests The Food and Drug Administration is poised to throw its support behind a powerful new method of predicting the safety of experimen
Pharmaceutical Companies and FDA Making Strides Developing a new drug is a costly and time-intensive venture. It often takes years to safely develop, test, and ultimately gain Fo
